Rejuve Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: transparent, low-cost compounded GLP-1, no membership, HSA/FSA eligible
Price is where Rejuve Meds scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no membership fees, free shipping, and HSA/FSA eligibility. Intro pricing starts around $85 for the first month. Medication is fulfilled through its "Rejuve Meds Pharmacy Network"; the individual pharmacies, prescribing medical group, and state-availability list are not named on the marketing site.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Rejuve Meds
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Rejuve Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Dual-action tirzepatide
- Starting price
- $165/mo (starting dose) ($165/mo; intro from $85 first month; $120 summer discount auto-applied; free shipping)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Rejuve Meds
Each dimension is scored algorithmically from Rejuve Meds’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.1/10At $165/mo (starting dose), Rejuve Meds runs about 11% below the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.1/10Rejuve Meds offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.4/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.5/10Rejuve Meds's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.9/10Rejuve Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rejuve Meds review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $165–$265/mo across 2 dose/plan tiers (checked August 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Rejuve Meds
We walked Rejuve Meds’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a quick online evaluation/consultation to determine if GLP-1 medication is right for you.
- 2A licensed provider reviews your information and issues approval (a synchronous consult is arranged only if your state requires it).
- 3If approved, a prescription and personalized care plan are created.
- 4Medication is shipped directly to your door, with ongoing care-team support.
- Pricing shown before intake: Tirzepatide $265/mo, starting as low as $85 for the first month with a $120-off promo; prices range $205-$399 after promotional pricing depending on medication.
- The lowest advertised price applies to a 12-month plan paid upfront or via buy-now-pay-later; actual price depends on product/plan.
- Cash-pay, no insurance required, and no membership fees; transparent-pricing claim.
- Choice of compounded or FDA-approved brand-name medication; free, discreet shipping.
- LegitScript approved; a Refund and Cancellation Policy is referenced.
GLP-1 medications Rejuve Meds offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$165/mo; intro from $85 first month; $120 summer discount auto-applied; free shipping
Dual-action GLP-1/GIP compounded formulation; $265/mo
Ready to get started?
Plans and promotions change often, so check Rejuve Meds's current pricing and active discounts before you decide.
What we like
- Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
- No membership fees, with everything included and free shipping
- HSA/FSA eligible; intro pricing from $85 for the first month
- Doctor-guided programs with personalized care
- Names a "Rejuve Meds Pharmacy Network" for fulfillment
Watch-outs
- Individual compounding pharmacies not named (only a "pharmacy network")
- Prescribing medical group not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Is Rejuve Meds worth it?
Rejuve Meds built its program around one core idea: transparent, low-cost compounded GLP-1, no membership, HSA/FSA eligible. It runs $165/month (starting dose); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
It charges no membership fee and takes HSA/FSA payment.
How much Rejuve Meds costs
Compounded semaglutide runs $165/month (starting dose) and compounded tirzepatide runs $265/month (starting dose).
Because Rejuve Meds's headline figure is a starting dose, we don't set it against the roughly $185 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Rejuve Meds with the month-to-month prices of the alternatives below instead.
HealthRX (about $165/month) is one of the closest alternatives to weigh Rejuve Meds against.
Medications: what Rejuve Meds prescribes
Rejuve Meds prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Rejuve Meds is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Rejuve Meds is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Price is where Rejuve Meds scores best in our breakdown.
Ready to start with Rejuve Meds?
From $165/mo (starting dose). See current pricing and start your free consultation.
Rejuve Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Rejuve Meds vs…
Rejuve Meds scores7.5/10
Side-by-side pricing, medications and scores. Pick a matchup.
Rejuve Meds vs Amazon One Medical
Amazon One Medical scores 8.5/10
Rejuve Meds vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rejuve Meds review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rejuve Meds's current pricing
Plans from $165/mo (starting dose). Start your free consultation to check eligibility and today's price.